VANGUARD GROUP INC - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 149 filers reported holding AMICUS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$329,923,577
-2.8%
27,131,873
+0.4%
0.01%0.0%
Q2 2023$339,426,679
+13.9%
27,024,417
+0.6%
0.01%0.0%
Q1 2023$297,898,970
-8.1%
26,861,945
+1.2%
0.01%
-11.1%
Q4 2022$324,033,510
+20.0%
26,538,371
+2.6%
0.01%
+12.5%
Q3 2022$270,095,000
-2.3%
25,871,062
+0.5%
0.01%0.0%
Q2 2022$276,363,000
+13.7%
25,732,089
+0.3%
0.01%
+33.3%
Q1 2022$242,973,000
-18.0%
25,657,170
+0.0%
0.01%
-14.3%
Q4 2021$296,202,000
+26.7%
25,645,184
+4.7%
0.01%
+16.7%
Q3 2021$233,866,000
-1.9%
24,488,601
-1.0%
0.01%0.0%
Q2 2021$238,392,000
-1.1%
24,729,400
+1.4%
0.01%
-14.3%
Q1 2021$240,945,000
-56.2%
24,387,053
+2.3%
0.01%
-56.2%
Q4 2020$550,591,000
+68.2%
23,845,433
+2.8%
0.02%
+45.5%
Q3 2020$327,409,000
-10.0%
23,187,567
-3.8%
0.01%
-15.4%
Q2 2020$363,620,000
+63.2%
24,112,736
-0.0%
0.01%
+44.4%
Q1 2020$222,856,000
-3.7%
24,118,586
+1.5%
0.01%
+12.5%
Q4 2019$231,414,000
+23.9%
23,759,160
+2.0%
0.01%
+14.3%
Q3 2019$186,734,000
-33.0%
23,283,609
+4.3%
0.01%
-30.0%
Q2 2019$278,687,000
+3.4%
22,330,661
+12.7%
0.01%
-9.1%
Q1 2019$269,559,000
+63.9%
19,820,543
+15.4%
0.01%
+57.1%
Q4 2018$164,507,000
-19.0%
17,171,997
+2.2%
0.01%
-12.5%
Q3 2018$203,205,000
-20.0%
16,807,772
+3.3%
0.01%
-27.3%
Q2 2018$254,082,000
+7.9%
16,266,464
+3.9%
0.01%
+10.0%
Q1 2018$235,441,000
+20.0%
15,654,294
+14.8%
0.01%
+11.1%
Q4 2017$196,204,000
-2.0%
13,634,785
+2.7%
0.01%0.0%
Q3 2017$200,275,000
+118.1%
13,280,868
+45.7%
0.01%
+80.0%
Q2 2017$91,821,000
+48.2%
9,118,246
+5.0%
0.01%
+66.7%
Q1 2017$61,944,000
+49.6%
8,687,760
+4.2%
0.00%
+50.0%
Q4 2016$41,419,000
-29.7%
8,333,811
+4.7%
0.00%
-33.3%
Q3 2016$58,879,000
+53.3%
7,956,543
+13.1%
0.00%
+50.0%
Q2 2016$38,404,000
-30.2%
7,033,500
+8.1%
0.00%
-50.0%
Q1 2016$55,005,000
-8.9%
6,509,450
+4.5%
0.00%0.0%
Q4 2015$60,408,000
-86.1%
6,227,567
-66.5%
0.00%
-75.0%
Q3 2015$435,464,000
+836.0%
18,566,132
+464.7%
0.02%
+433.3%
Q2 2015$46,526,000
+67.6%
3,288,076
+28.9%
0.00%
+50.0%
Q1 2015$27,752,000
+40.3%
2,550,728
+7.3%
0.00%
+100.0%
Q4 2014$19,783,000
+87.5%
2,377,689
+34.1%
0.00%0.0%
Q3 2014$10,551,000
+132.1%
1,773,331
+30.3%
0.00%
Q2 2014$4,546,000
+78.3%
1,361,170
+10.5%
0.00%
Q1 2014$2,550,000
-8.9%
1,231,741
+3.5%
0.00%
Q4 2013$2,798,000
+10.5%
1,190,481
+9.1%
0.00%
Q3 2013$2,532,000
-0.5%
1,091,462
-0.1%
0.00%
Q2 2013$2,546,0001,092,6970.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,114,043$116,817,0007.46%
Parametrica Management Ltd 597,279$6,899,0006.86%
Redmile Group, LLC 22,716,086$262,371,0005.96%
Perceptive Advisors 53,118,886$613,524,0004.73%
Asymmetry Capital Management, L.P. 716,709$8,278,0004.39%
CM Management, LLC 450,000$5,198,0003.93%
Avoro Capital Advisors LLC 18,500,000$213,675,0003.64%
Kynam Capital Management, LP 573,699$6,626,0003.54%
SECTORAL ASSET MANAGEMENT INC 1,242,882$14,355,0002.16%
Ghost Tree Capital, LLC 500,000$5,775,0002.07%
View complete list of AMICUS THERAPEUTICS INC shareholders